BU-NOT-SET

CONTACT US
Unlocking the potential of RNA therapeutics through innovation and collaboration
  • Biologics
RNA
Insight
Using in vitro release testing (IVRT) to analyse semi-solid topical formulations
  • Analytical chemistry
Cream squeezed out of a tube
White paper
Enhancing the production of RNA with continuous manufacturing
  • Biologics
Continuous manufacturing of RNA
Insight
GERTEIS MINI-PACTOR® Advanced dry granulation services
  • Drug product
GERTEIS MINI-PACTOR®
Fact sheet
Overcoming oncolytic virus therapy production challenges through collaboration
  • Biologics
Oncolytic virus therapy production
Case study
Emerging trends set to impact drug development in 2024
  • Industry trends
Trends in drug development
Insight
Webinar: ATMPs in focus: Essential CMC strategies for every phase
  • Biologics
ATMPs in focus
Webinar
Trends set to make an impact on oral solid dose development in 2024
  • Drug product
  • Industry trends
Oral solid dose
Insight
Enhancing AAV therapy development and manufacture with a platform approach
  • Biologics
Enhancing AAV therapy
Insight
Report
  • Sustainability
Sustainability Report 2021
Insight
  • Corporate
Treating long-COVID with Erdosteine
Insight
  • Drug product
Three trends driving small molecule API market growth
Fact sheet
  • Drug product
Vaccine manufacturing
Insight
  • Drug product
Solving the challenges during oral solid dosage development
Insight
  • Drug product
mRNA vaccine manufacturing: how to unlock success
Insight
  • Manufacturing
Pharma packaging trends under the spotlight
Insight
  • Drug product
Modified release formulation and manufacture
Webinar
  • Drug product
Aseptic manufacturing – design of lines for filling and lyophilisation